Institutional Biosafety Committee
The Institutional Biosafety Committee (IBC) is a University-wide group Committee responsible for reviewing and approving recombinant or synthetic nucleic acid molecules research and biohazard research projects. The IBC has overall oversight responsibility for the Biosafety Program at Boston University and Boston Medical Center. The IBC carries out these functions pursuant to requirements set forth by federal, state, and local agencies as well as Boston University.
View the latest IBC Newsletter.
Submit a New Application to the IBC
Print my Approval Documentation